InvestorsHub Logo
Followers 13
Posts 1091
Boards Moderated 0
Alias Born 07/19/2013

Re: None

Wednesday, 02/24/2021 7:31:18 PM

Wednesday, February 24, 2021 7:31:18 PM

Post# of 507
Got goosebumps when I found out that BTHE CEO Conroy Cheng has been involved with Nanomix since 2017.

EMERYVILLE, Calif., Nov. 9, 2017 /PRNewswire/ -- Nanomix, Inc., a developer of next-generation, mobile, point-of-care diagnostics, today announced the completion of a comprehensive equity investment and business collaboration with the World Technology East 2, RedPharm Biotechnology Ltd., and the associated entities in Hong Kong, China and the European Community. The relationship focuses on the use and deployment of Nanomix products and technology throughout Asia for human applications and worldwide veterinary applications in farm animal, companion animal, and wildlife management and control.

"As part of our integrated healthcare business strategy, we are investing in these advanced healthcare products and technologies to help meet the demand for high quality, precise, immediate and available healthcare diagnosis at an affordable cost for all people in the China and Asia sphere," said Conroy Cheng, Director of World Technology East and RedPharm Biotechnology Ltd. "The Nanomix technology and allied products will deliver critical advanced diagnostic tools and information for multiple markets."


https://www.prnewswire.com/news-releases/nanomix-announces-equity-financing-and-collaboration-with-hong-kong-beijing-based-world-technology-east-and-redpharm-biotechnology-companies-300552518.html